Intellipharmaceutics International Inc. (IPCI)

[Tekterra]

Just life in the market Fabius. Those who got in around 2.3 was smart. But those who chase at 2.8 or higher today is already being slapped in the face. But who's to say the deal isn't real? Win or lose, we will find out.

The rumor does make some sense though. IPCI was developing Rexista, Regataton and PODRAS. That's what they been doing in the past year. The deal on all three does make sense for somebody who's looking to compete in the ADF market.

Companies like EGLT with their guardian technology, and here we have nPODDDS and PODRAS. A company like Novartis that's looking to enter NASH market and ADF market would no doubt be looking at these technologies including their deal with CNAT. CNAT got a 50 mill up front which took their stock from 2 to 5. Should Novartis decides to license CNAT's product they are entitled up to 650 million in milestone payment.

NASH and ADF is really heating up in the recent year, and any big pharma will want to set themselves up for profitable future.